Novartis Aktie
109,55
EUR
-0,95
EUR
-0,86
%
103,00
CHF
+0,12
CHF
+0,12
%
Werbung
Novartis Aktie Analyse
| 18.07.23 | Novartis Neutral | UBS AG | |
| 18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 09.01.23 | Novartis Neutral | UBS AG | |
| 03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 01.07.22 | Novartis Neutral | UBS AG | |
| 22.06.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 17.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Equal-weight | Morgan Stanley | |
| 03.02.22 | Novartis Neutral | UBS AG | |
| 03.02.22 | Novartis Neutral | Credit Suisse Group | |
| 02.02.22 | Novartis Market-Perform | Bernstein Research | |
| 14.01.22 | Novartis Equal-weight | Morgan Stanley | |
| 07.01.22 | Novartis Neutral | UBS AG | |
| 13.12.21 | Novartis Neutral | Credit Suisse Group | |
| 03.12.21 | Novartis Neutral | UBS AG | |
| 26.11.21 | Novartis Neutral | UBS AG | |
| 05.11.21 | Novartis Neutral | UBS AG | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group | |
| 12.10.21 | Novartis Market-Perform | Bernstein Research | |
| 17.09.21 | Novartis Hold | Deutsche Bank AG | |
| 13.09.21 | Novartis Hold | Deutsche Bank AG | |
| 06.09.21 | Novartis Hold | Kepler Cheuvreux | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
Werbung
Werbung